Working Groups
We welcome you to choose how you participate.
In 2021, we have established four unique working groups to address needs and opportunities to make meaningful impacts in the areas of: Health Equity: Racial & Ethnic Health and Healthcare Disparities; Health Equity: Access to Care; Patient Voice/Patient-Focused Drug Development (PFDD); and The Future of Advocacy. We welcome you to choose how you participate in one or more of these working groups to use your voice to lead, or learn from others about the progress they are bringing to life.
Select the working group in which you’d like to participate by registering below.
Working Group Descriptions
Health Equity:
Racial & Ethnic Health and Healthcare Disparities
Where we live should not determine if we live. The structural, institutional and systemic disparities need to be corrected for everyone to have equitable healthcare.
This working group will utilize courageous conversations to better understand the current environment and be part of taking tangible steps towards correcting inequities.
Team: Sheila Thorne, Jessica Valence, Kemi Osundina, Tammi Fanson
Health Equity:
Access to Care
Advancements in medicine and technology are creating better outcomes than ever, which makes the disparities in accessing care even more devastating.
This working group will take an unflinching look at current access to care to define and then contribute to the change needed.
Team: Brad Love, Eileen Shannon, Brian Lee, Nilam Perpich
Patient Voice/Patient-Focused Drug Development
Patient involvement is increasingly being recognized as important to successful research and development of medicines and care. Patient-focused drug development...
(PFDD) is an emerging set of practices for engagement with patients and generating data on patients’ and caregivers’ experience. This working group will consider current guidances and practices to identify needed tools and resources to further promote and embed good practices.
Team: Neil Bertelsen, Christian Bullock, Miryah Morris, Birgit Roy
The Future
of Advocacy
The role of patient advocacy organizations is changing. There are increased demands, new challenges, and also emerging opportunities for creating meaningful...
change within the healthcare system. This working group will define where advocacy has been, where it is today, and create tangible steps toward defining the future of advocacy.
Team: Gary Nolan, Lauren Lastauskas, Chad Saward
Upcoming Session
Outlining Our Paths to Impact and Change
During February’s COVID Advocacy Exchange session, we launched the 2021 Working Groups, each focused on creating meaningful change in a high-priority area, including Health Equity: Racial & Ethnic Health and Healthcare Disparities; Health Equity: Access to Care; Patient Voice/Patient-Focused Drug Development (PFDD); and The Future of Advocacy.